Future applications could include treatment for disfigurement after radical cancer surgery
A breakthrough by Israeli researchers could speed recovery and limit scarring and disfigurement for patients who have suffered large soft tissue trauma – as often occurs with serious injury or cancer surgery. By biomedically engineering a muscle flap that includes a patient’s own blood vessels, the team has created tissue that could be transferred to other parts of the body along with the patient’s blood supply. Current techniques for reconstructing such trauma – including grafts and synthetic material – often fail because of lost blood supply.
Led by Professor Shulamit Levenberg, of the Department of Biomedical Engineering and the Russell Berrie Nanotechnology Institute at the Technion-Israel Institute of Technology (http://www.technion.ac.il/en), the scientists fabricated the muscle flap using a variety of added cells and connective tissues to strengthen it. They then tested the flap by reconstructing deep abdominal wall tissue defects in mice.
Their paper describing how the muscle flap was engineered, its advantages, and its successful use when tested in an animal model, appears this week in the Online Early Edition of the Proceedings of the National Academy of Sciences ([ http://www.pnas.org ]www.pnas.org).
According to Levenberg, successful reconstruction of large, soft tissue defects has been a clinical challenge in the past.
To improve outcomes, the researchers developed the unique muscle flap using a patient’s own tissues (autologous), added important and advantageous cellular components to strengthen it, and engineered the flap in such a way as to vascularize to include the patient’s own blood vessels so that the patient retains their own blood supply during the reconstruction process.
“We set out to design and evaluate an engineered muscle flap with robust vascularization,” says Levenberg, whose research focuses on vascularization of engineered tissues. “Proper vascularization is essential for successfully integrating the flap within the host.”
Their study, said the researchers, provides evidence that tissue-specific cells, such as myoblasts (cells that form muscles), endothelial cells (the thin layer of cells that lines the interior surface of blood vessels), and fibroblasts (the cells providing the structural framework for animal tissues), are necessary for successful muscle flap engineering as the added cells “rapidly and more effectively integrated within the host tissue.”
“The cell types integrated in the engineered flaps dictate the muscle flap’s mechanical strength,” adds Levenberg.
The researchers report that within one week of transferring the engineered muscle flaps into the test mice the flaps were “viable, highly vascularized,” and demonstrated “firm attachment to the surrounding tissues.” They also note that the muscle flaps had the mechanical strength to support the “abdominal viscera,” or organs in the abdominal region.
Their positive results, say the researchers, will not only stimulate more research, but also lead to clinical studies with human patients. They also suggest that there are far-reaching uses of the muscle flap as it can be transferred as a “free flap” to reconstruct defects in other parts of the body. This advantage could circumvent the need to harvest and transfer large amounts of tissue, avoiding many of the current complications.
“When the flap is made with a viable blood vessel network, larger quantities of tissue, even a whole organ, can be implanted and then coupled to the main vessel trunk by attaching the blood vessel network of the engineered tissue to host vessels,” conclude the researchers.
The Latest on: Biomedical engineering
via Google News
The Latest on: Biomedical engineering
- Case-Coulter Translational Research Partnership awards $1.9 million to biomedical engineering technologieson October 14, 2021 at 10:59 am
With support from JobsOhio as part of the Cleveland Innovation District initiative, the research partnership at Case Western Reserve University selected 10 projects to receive awards ranging from $50, ...
- Pharmaceutical Sciences Major Combines Science and Business Classeson October 14, 2021 at 10:56 am
The major in pharmaceutical sciences combines classes in biomedical sciences and business to prepare students for jobs in pharmaceutical and biotechnology companies. Students can go on for advanced ...
- CC* Compute: A Balanced Cluster For Science and Engineering in the Great Lakes Regionon October 14, 2021 at 8:36 am
ABSTRACT The University of Wisconsin-Milwaukee (UWM) is building and deploying a modern, high-performance, high-throughput, and compute-on-demand cluster that balances the growing ...
- HHMI philanthropy devotes $2 billion to boost inclusion and equity in biomedical scienceson October 14, 2021 at 3:00 am
While HHMI has promoted diversity through smaller programs for years, its president said the efforts have not been “coherent or systematic.” ...
- Biomedical engineering: Exoskeleton improves walking in patients with above-knee amputationon October 11, 2021 at 7:05 pm
An autonomous, powered hip exoskeleton capable of improving walking for people with above-knee amputation is presented in an early-stage clinical study published in Nature Medicine. For the millions ...
- Fairfield U School Of Engineering Launches StagHack Competitionon October 9, 2021 at 9:30 am
High school seniors will have the opportunity to compete in Fairfield University School of Engineering's inaugural hackathon competition, StagHack. The competition will be offered in two formats: ...
- Cutting edge tech: Albany company makes 3D printed medical models for surgery practiceon October 9, 2021 at 6:30 am
A company that’s on the bleeding edge of biomedical engineering is based in Albany. Lazarus 3D, a company that uses 3D printing to produce realistic medical models of organs and ...
- Craig Simmons named 2021 Biomedical Engineering Society Fellowon October 8, 2021 at 1:12 pm
Craig Simmons of the Faculty of Applied Science & Engineering has been inducted as a Fellow of the Biomedical Engineering Society in recognition of his innovative and wide-ranging contributions to ...
- Biomedical engineering professor receives $2.6M NIH grant to research brain disorderson October 8, 2021 at 6:30 am
Nikolaos Tsoukias — who is an associate professor at the College of Engineering and Computing in the Department of Biomedical Engineering (BME) — has been awarded a five-year, $2.6 million grant by ...
- Landmark paper highlights Evox Therapeutics' cutting edge exosome engineering approach for enhanced surface display of biologicson October 6, 2021 at 11:00 pm
Evox's engineered exosomes show better efficacy compared to conventional biologics and significantly outperformed other previously published exosome display platforms ...
via Bing News